Location · Tupelo, MS
Clinical trials in Tupelo, MS
12 recruiting studies have a site in Tupelo, and 1 of them accept healthy volunteers.
12 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Xencor, Inc.
- Location
- Tupelo, MS + 27 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Virtue® SAB in the Treatment of Coronary ISR Trial
Orchestra BioMed, Inc
- Location
- Tupelo, MS + 21 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
SPYRAL GEMINI Pilot Study
Medtronic Vascular
- Location
- Tupelo, MS + 11 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Boehringer Ingelheim
- Location
- Tupelo, MS + 55 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
EVERO Drug-coated Balloon (DCB) Randomized Trial
Cook Research Incorporated
- Location
- Tupelo, MS + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Amgen
- Location
- Tupelo, MS + 136 other US sites
- Eligibility basics
- Ages 45–99
- RecruitingPhase 2
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
Novartis Pharmaceuticals
- Location
- Tupelo, MS + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Maze Therapeutics
- Location
- Tupelo, MS + 58 other US sites
- Eligibility basics
- Ages 18–68
- Recruiting
The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism
Thrombolex, Inc.
- Location
- Tupelo, MS + 22 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Tupelo, MS + 112 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 3
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Alebund Pharmaceuticals
- Location
- Tupelo, MS + 17 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Concept Medical Inc.
- Location
- Tupelo, MS + 23 other US sites
- Eligibility basics
- Ages 18–110